Ero Copper Corp (ERO)vsVersamet Royalties Corporation Common Stock (VMET)
ERO
Ero Copper Corp
$36.48
-2.17%
BASIC MATERIALS · Cap: $3.62B
VMET
Versamet Royalties Corporation Common Stock
$9.13
-0.98%
BASIC MATERIALS · Cap: $1.03B
Smart Verdict
WallStSmart Research — data-driven comparison
Ero Copper Corp generates 1308% more annual revenue ($1.04B vs $74.18M). VMET leads profitability with a 49.9% profit margin vs 29.8%. ERO trades at a lower P/E of 11.8x. ERO earns a higher WallStSmart Score of 76/100 (B+).
ERO
Strong Buy76
out of 100
Grade: B+
VMET
Buy60
out of 100
Grade: C+
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-4.8%
Fair Value
$30.07
Current Price
$36.48
$6.41 premium
Intrinsic value data unavailable for VMET.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Attractively priced relative to earnings
Every $100 of equity generates 33 in profit
Strong operational efficiency at 37.6%
Revenue surging 73.9% year-over-year
Keeps 30 of every $100 in revenue as profit
Earnings expanding 25.0% YoY
Keeps 50 of every $100 in revenue as profit
Strong operational efficiency at 58.0%
Revenue surging 391.9% year-over-year
Earnings expanding 2123.0% YoY
Reasonable price relative to book value
Areas to Watch
No major concerns identified
Moderate valuation
Smaller company, higher risk/reward
Distress zone — elevated risk
Comparative Analysis Report
WallStSmart ResearchBull Case : ERO
The strongest argument for ERO centers on P/E Ratio, Return on Equity, Operating Margin. Profitability is solid with margins at 29.8% and operating margin at 37.6%. Revenue growth of 73.9% demonstrates continued momentum.
Bull Case : VMET
The strongest argument for VMET centers on Profit Margin, Operating Margin, Revenue Growth. Profitability is solid with margins at 49.9% and operating margin at 58.0%. Revenue growth of 391.9% demonstrates continued momentum.
Bear Case : ERO
No major red flags identified for ERO, but monitor valuation.
Bear Case : VMET
The primary concerns for VMET are P/E Ratio, Market Cap, Altman Z-Score.
Key Dynamics to Monitor
VMET is growing revenue faster at 391.9% — sustainability is the question.
ERO generates stronger free cash flow (52M), providing more financial flexibility.
Monitor COPPER industry trends, competitive dynamics, and regulatory changes.
Bottom Line
ERO scores higher overall (76/100 vs 60/100), backed by strong 29.8% margins and 73.9% revenue growth. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Ero Copper Corp
BASIC MATERIALS · COPPER · USA
Ero Copper Corp. The company is headquartered in Vancouver, Canada.
Versamet Royalties Corporation Common Stock
BASIC MATERIALS · OTHER PRECIOUS METALS & MINING · USA
Viamet Pharmaceuticals Corp (VMET) is an innovative biopharmaceutical company dedicated to the development of advanced therapeutics targeting serious diseases, particularly in the areas of fungal infections and oncology, utilizing its proprietary metalloenzyme-based technology platform. With a robust and diversified clinical pipeline supported by strategic partnerships and a comprehensive intellectual property portfolio, Viamet is strategically positioned for significant growth. The company remains focused on addressing critical unmet medical needs and is committed to enhancing shareholder value through continued therapeutic advancements in its specialized areas.
Compare with Other COPPER Stocks
Want to dig deeper into these stocks?